Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis

被引:79
|
作者
Okamura, Daryl M. [1 ]
Pasichnyk, Katie
Lopez-Guisa, Jesus M.
Collins, Sarah
Hsu, Daniel K. [2 ]
Liu, Fu-Tong [2 ]
Eddy, Allison A.
机构
[1] Univ Washington, Seattle Childrens Res Inst, Div Nephrol, Dept Pediat, Seattle, WA 98105 USA
[2] Univ Calif Davis, Med Ctr, Div Res Dermatol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
chronic kidney disease; nephron loss; matrix degradation; tubular apoptosis; defective tissue remodeling; GALECTIN-3/AGE-RECEPTOR-3 KNOCKOUT MICE; EXPERIMENTAL MURINE SCHISTOSOMIASIS; INTRACELLULAR COLLAGEN DEGRADATION; INTERSTITIAL FIBROSIS; PICROSIRIUS-POLARIZATION; OBSTRUCTIVE NEPHROPATHY; CELL-GROWTH; APOPTOSIS; RECEPTOR; INJURY;
D O I
10.1152/ajprenal.00326.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Okamura DM, Pasichnyk K, Lopez-Guisa JM, Collins S, Hsu DK, Liu F, Eddy AA. Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. Am J Physiol Renal Physiol 300: F245-F253, 2011. First published October 20, 2010; doi: 10.1152/ajprenal.00326.2010.-Renal tubular cell apoptosis is a critical detrimental event that leads to chronic kidney injury in association with renal fibrosis. The present study was designed to investigate the role of galectin-3 (Gal-3), an important regulator of multiple apoptotic pathways, in chronic kidney disease induced by unilateral ureteral obstruction (UUO). After UUO, Gal-3 expression significantly increased compared with basal levels reaching a peak increase of 95-fold by day 7. Upregulated Gal-3 is predominantly tubular at early time points after UUO but shifts to interstitial cells as the injury progresses. On day 14, there was a significant increase in TdT-mediated dUTP nick end labeling-positive cells (129%) and cytochrome c release (29%), and a decrease in BrdU-positive cells (62%) in Gal-3-deficient compared with wild-type mice. The degree of renal damage was more extensive in Gal-3-deficient mice at days 14 and 21, 35 and 21% increase in total collagen, respectively. Despite more severe fibrosis, myofibroblasts were significantly decreased by 58% on day 14 in the Gal-3-deficient compared with wild-type mice. There was also a corresponding 80% decrease in extracellular matrix synthesis in Gal-3-deficient compared with wild-type mice. Endo180 is a recently recognized receptor for intracellular collagen degradation that is expressed by interstitial cells during renal fibrogenesis. Endo180 expression was significantly decreased by greater than 50% in Gal-3-deficient compared with wild-type mice. Taken together, these results suggested that Gal-3 not only protects renal tubules from chronic injury by limiting apoptosis but that it may lead to enhanced matrix remodeling and fibrosis attenuation.
引用
收藏
页码:F245 / F253
页数:9
相关论文
共 50 条
  • [21] Extracellular galectin-3 in tumor progression and metastasis
    Fortuna-Costa, Anneliese
    Gomes, Angelica M.
    Kozlowski, Eliene O.
    Stelling, Mariana P.
    Pavao, Mauro S. G.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [22] Blocking extracellular Galectin-3 in patients with osteoarthritis
    Andrews, Alec R.
    Fernandes, Ana D.
    Brownmiller, Seth E.
    Hanna, Yousif
    Fisher, Mark C.
    Huang, Christene A.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 17
  • [23] Extracellular matrix as a driver of progressive fibrosis
    Herrera, Jeremy
    Henke, Craig A.
    Bitterman, Peter B.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (01): : 45 - 53
  • [24] Galectin-3, Cardiac Function, and Fibrosis Reply
    Frunza, Olga
    Russo, Ilaria
    Shinde, Arti V.
    Su, Ya
    Frangogiannis, Nikolaos G.
    AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (08): : 2234 - 2235
  • [25] Galectin-3 antagonists with therapeutic implications in fibrosis
    Nilsson, Ulf
    Leffler, Hakon
    Schambye, Hans
    Mackinnon, Alison
    Sethi, Tariq
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [26] Galectin-3 promotes fibrosis in ovarian endometriosis
    Yang, Guimin
    Deng, Yupeng
    Cao, Guangming
    Liu, Chongdong
    PEERJ, 2024, 12
  • [27] Galectin-3 levels in children with cystic fibrosis
    Ademhan Tural, Dilber
    Emiralioglu, Nagehan
    Akin, Senay
    Alboga, Didem
    Ozsezen, Beste
    Nayir Buyuksahin, Halime
    Guzelkas, Ismail
    Kasikci, Merve
    Sunman, Birce
    Gungor, Irem
    Yalcin, Ebru
    Dogru, Deniz
    Kiper, Nural
    Demirel, Ali Haydar
    Ozcelik, Ugur
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (05) : 2333 - 2342
  • [28] Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo
    Jiang, Joy X.
    Chen, Xiangling
    Hsu, Daniel K.
    Baghy, Kornelia
    Serizawa, Nobuko
    Scott, Fiona
    Takada, Yoshikazu
    Takada, Yoko
    Fukada, Hiroo
    Chen, Jenny
    Devaraj, Sridevi
    Adamson, Roger
    Liu, Fu-Tong
    Toeroek, Natalie J.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 302 (04): : G439 - G446
  • [29] Galectin-3 enhances extracellular matrix associations and wound healing in monkey corneal epithelium
    Fujii, Atsuko
    Shearer, Thomas R.
    Azuma, Mitsuyoshi
    EXPERIMENTAL EYE RESEARCH, 2015, 137 : 71 - 78
  • [30] Galectin-3 Predicts Left Ventricular Remodeling of Hypertension
    Yao, Yongwei
    Shen, Dongli
    Chen, Rong
    Ying, Chunyang
    Wang, Chenghua
    Guo, Junfang
    Zhang, Guohui
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (06): : 506 - 511